A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Name: A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Published: 2026
License: Public Domain

Eli Lilly and Company · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

atherosclerosis c-reactive-protein cardiovascular-disease cardiovascular-risk chronic diabetes-mellitus hypertension monoclonal-antibody

atherosclerosis, cardiovascular disease, obesity, hypertension, diabetes mellitus, type 2, renal insufficiency, chronic, interleukin-6 (il-6), il-6 inhibition, c-reactive protein, residual inflammatory risk, cardiovascular risk, monoclonal antibody

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 898328
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.